Profile data is unavailable for this security.
About the company
Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of materials for use in advanced woundcare products and surgical dressings, as well as medical adhesives and sutures for closing and sealing tissue. It operates through four segments: Branded Direct, Branded Distributed, OEM (Original Equipment Manufacturer) and Bulk Materials. Its Branded Direct segment is engaged in selling, marketing and innovation of its branded products sold directly by its sales teams. Its Branded Distributed segment is engaged in distribution, marketing and innovation of its brands sold by distributors in markets not serviced by its sales team. Its OEM segment is engaged in selling, marketing and innovation of its products supplied to partners under their brands. Its Bulk Materials segment is engaged in selling, marketing and innovation of bulk materials to medical device partners and convertors. Its products include ActivHeal, LiquiBand and RESORBA.
- Revenue in GBP (TTM)103.69m
- Net income in GBP20.57m
- Incorporated1993
- Employees654.00
- LocationAdvanced Medical Solutions Group PLCPremier Park, 33 Road OneWINSFORD CW7 3RTUnited KingdomGBR
- Phone+44 160 686 3500
- Fax+44 160 686 3600
- Websitehttp://www.admedsol.com/
More ▼
Mergers & acquisitions
| Acquired company | AMS:LSE since announced | Transaction value |
|---|---|---|
| Biomatlante SA | 2.49% | 8.81m |
Data delayed at least 20 minutes, as of Feb 25 2020 12:02 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Basilea Pharmaceutica AG | 90.70m | -17.72m | 448.21m | 225.00 | -- | -- | -- | 4.94 | -2.08 | -2.08 | 10.67 | -8.63 | 0.4562 | 1.14 | 22.96 | 510,160.00 | -8.91 | -11.64 | -12.42 | -14.97 | 83.56 | -- | -19.53 | -43.44 | 2.20 | -2.69 | 1.89 | -- | 8.19 | 21.98 | 28.48 | -- | -20.99 | -- |
| Alliance Pharma plc | 129.76m | 21.67m | 452.18m | 210.00 | 20.85 | 1.72 | 19.21 | 3.48 | 0.041 | 0.041 | 0.2453 | 0.4969 | 0.3214 | 2.94 | 6.26 | 617,904.80 | 5.37 | 6.62 | 7.00 | 7.87 | 62.83 | 58.75 | 16.70 | 21.10 | 0.4659 | 8.46 | 0.2672 | 31.80 | 16.30 | 21.16 | -36.33 | 13.88 | -21.58 | 10.02 |
| Boiron SA | 487.25m | 29.77m | 465.46m | 3.57k | 15.62 | 1.22 | 7.73 | 0.9553 | 2.02 | 2.02 | 33.12 | 25.96 | 0.8094 | 1.87 | 8.01 | 158,061.00 | 4.94 | 10.35 | 6.12 | 13.23 | 77.14 | 79.55 | 6.10 | 12.32 | 2.09 | -- | 0.0317 | 38.77 | -2.16 | -0.4416 | -26.56 | -6.96 | 14.32 | 3.86 |
| Opus Global Nyrt | 307.60m | 50.25m | 472.07m | 3.94k | 4.81 | 0.8394 | 5.65 | 1.53 | 56.39 | 67.65 | 345.16 | 322.84 | 0.4017 | 6.66 | 5.35 | 31,486,840.00 | 5.30 | 5.65 | 9.52 | 10.22 | 21.90 | 33.17 | 13.20 | 19.51 | 0.8784 | -- | 0.255 | -- | -5.00 | 28.05 | 271.59 | 75.46 | 360.50 | -- |
| Oxford BioMedica plc | 63.59m | -7.81m | 484.29m | 377.00 | -- | 6.03 | -- | 7.62 | -0.1146 | -0.1146 | 0.9181 | 1.04 | 0.553 | 6.02 | 3.04 | 168,684.30 | -6.79 | -14.68 | -9.41 | -19.78 | 61.64 | 60.85 | -12.28 | -24.62 | 2.12 | -1.07 | 0.0955 | -- | 77.65 | 65.52 | 183.63 | -- | 61.04 | -- |
| Genfit SA | 6.49m | -80.71m | 488.03m | 174.00 | -- | 6.05 | -- | 75.21 | -3.08 | -3.08 | 0.2479 | 2.47 | 0.0263 | 511.00 | 5.02 | 60,382.81 | -32.74 | -27.28 | -37.81 | -30.93 | 73.55 | 70.86 | -1,243.90 | -629.36 | 6.44 | -5.91 | 0.6505 | -- | 9.31 | 4.66 | -42.69 | -- | 65.09 | -- |
| Oncopeptides AB | 0.00 | -58.86m | 532.81m | 73.00 | -- | 8.41 | -- | -- | -14.23 | -14.23 | 0.00 | 14.38 | 0.00 | -- | -- | -- | -106.79 | -109.07 | -133.68 | -137.31 | -- | -- | -- | -- | -- | -1,400.36 | -- | -- | -- | -- | -80.17 | -- | -- | -- |
| Selcuk Ecza Deposu Ticaret ve Sanayi AS | 2.25bn | 87.86m | 550.38m | 6.34k | 6.26 | 1.41 | 5.75 | 0.2444 | 1.12 | 1.12 | 28.68 | 4.98 | 2.39 | 10.20 | 11.66 | 2,808,938.00 | 9.33 | 7.07 | 24.07 | 16.73 | 8.28 | 7.78 | 3.90 | 3.14 | 1.12 | -- | 0.0849 | -- | 32.24 | 22.77 | 77.60 | 33.25 | 0.679 | -- |
| Cellectis SA | 15.00m | -68.28m | 554.62m | 149.00 | -- | 2.10 | -- | 36.98 | -1.92 | -1.92 | 0.421 | 7.40 | 0.0388 | -- | 3.94 | 119,911.20 | -20.08 | -18.99 | -24.45 | -25.03 | -- | 14.34 | -518.06 | -137.77 | 7.93 | -- | 0.1106 | -- | -36.43 | 24.66 | 20.81 | -- | 42.19 | -- |
| Vectura Group PLC | 172.30m | -78.00m | 565.18m | 453.00 | -- | 1.19 | 1,130.35 | 3.28 | -0.1267 | -0.1267 | 0.28 | 0.7798 | 0.2739 | 2.92 | 4.53 | 380,353.20 | -12.40 | -- | -13.67 | -- | 56.99 | -- | -45.27 | -- | 2.41 | -- | 0.017 | -- | 8.45 | -- | -1.03 | -- | -- | -- |
| Advanced Medical Solutions Group plc | 103.69m | 20.57m | 579.13m | 654.00 | 28.33 | 3.17 | 22.71 | 5.59 | 0.0951 | 0.0951 | 0.4794 | 0.8511 | 0.5146 | 2.78 | 4.92 | 158,548.90 | 10.21 | 12.43 | 10.96 | 13.63 | 60.40 | 59.28 | 19.84 | 20.59 | 6.08 | 106.25 | 0.0497 | 12.00 | 5.87 | 11.51 | 11.69 | 14.62 | 18.16 | 17.08 |
| Recipharm AB (publ) | 592.57m | 27.26m | 598.02m | 5.36k | 30.01 | 1.71 | 6.90 | 1.01 | 4.77 | 4.77 | 101.77 | 83.97 | 0.5633 | 2.80 | 5.53 | -- | 2.59 | 1.52 | 2.92 | 1.75 | 48.94 | 47.95 | 4.60 | 2.77 | 1.80 | 49.94 | 0.4778 | 36.73 | 17.00 | 23.75 | 115.24 | 16.45 | 11.35 | 6.59 |
| Dottikon ES Holding AG | 133.56m | 23.46m | 629.48m | 595.00 | 26.39 | 2.04 | 15.56 | 4.71 | 23.72 | 23.72 | 135.06 | 307.50 | 0.3666 | 0.4166 | 5.14 | 285,538.80 | 6.44 | 4.23 | 7.31 | 4.65 | 82.75 | 82.24 | 17.57 | 11.82 | 1.41 | 92.05 | 0.00 | 0.00 | -6.65 | 10.43 | -37.07 | -- | 54.28 | -- |
| Pharming Group N.V. | 134.50m | 31.34m | 644.71m | 183.00 | 22.50 | 8.50 | 17.60 | 4.79 | 0.0543 | 0.0543 | 0.2315 | 0.1437 | 0.7748 | 1.38 | 6.34 | 875,453.60 | 18.06 | -15.97 | 31.49 | -24.78 | 85.88 | 83.46 | 23.30 | -31.00 | 0.9983 | 1.80 | 0.4009 | -- | 50.78 | 81.59 | 132.78 | -- | 160.02 | -- |
| Biotest AG | 340.51m | -7.99m | 654.45m | 1.79k | -- | 1.50 | -- | 1.92 | -0.2664 | -0.3393 | 10.59 | 12.43 | 0.3793 | 1.30 | 2.88 | 243,896.60 | -0.8604 | 0.4722 | -0.9653 | 0.5619 | 29.91 | 37.85 | -2.27 | 0.9987 | 2.48 | -- | 0.4551 | 62.44 | 5.87 | -4.38 | 21.31 | -- | 4.94 | -- |
| Vetoquinol SA | 313.86m | 28.11m | 670.32m | 2.13k | 23.74 | 2.14 | 16.45 | 2.14 | 2.83 | 2.83 | 31.61 | 31.36 | 0.8033 | 2.30 | 4.95 | 175,358.80 | 7.15 | 7.03 | 8.69 | 8.87 | 47.16 | 60.04 | 8.90 | 8.64 | 1.63 | -- | 0.0363 | 17.29 | 4.48 | 4.19 | 4.10 | 8.99 | 13.53 | 5.34 |
Data as of Feb 25 2020. Currency figures normalised to Advanced Medical Solutions Group PLC's reporting currency: UK Pound GBX
49.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Octopus Investments Ltd.as of 08 Apr 2019 | 22.21m | 10.34% |
| AXA Investment Managers UK Ltd.as of 08 Apr 2019 | 17.22m | 8.02% |
| Hargreave Hale Ltd.as of 08 Apr 2019 | 14.37m | 6.69% |
| Investec Wealth & Investment Ltd.as of 08 Apr 2019 | 10.15m | 4.72% |
| Groupama Asset Management SAas of 08 Apr 2019 | 9.29m | 4.32% |
| Aviva Investors Global Services Ltd.as of 08 Apr 2019 | 8.43m | 3.93% |
| BlackRock Investment Management (UK) Ltd.as of 07 Feb 2020 | 7.49m | 3.49% |
| Kames Capital Plcas of 08 Apr 2019 | 6.56m | 3.05% |
| CA Indosuez Wealth (Private Banking Europe)as of 02 Nov 2019 | 5.30m | 2.47% |
| Rathbone Investment Management Ltd.as of 02 Nov 2019 | 4.61m | 2.15% |
More ▼
Data from 30 Sep 2019 - 31 Jan 2020Source: FactSet Research Systems Inc.
